Scythian Biosciences Corp. Announces Ringing of the Nasdaq Stock Market Closing Bell
22 févr. 2018 08h00 HE
|
Scythian Biosciences Corp.
TORONTO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that the Company will ring the...
Scythian Biosciences Announces Appointment of Professor Michael Barnes as Chief Medical Officer
15 févr. 2018 08h20 HE
|
Scythian Biosciences Corp.
- Influential voice in medical cannabis policy in Europe - A leading world authority in neurological rehabilitation TORONTO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the...
Scythian Biosciences Corp. Announces Approval for Listing on the Nasdaq Capital Markets under Symbol “SCYB” and Ringing of the Nasdaq Closing Bell
14 févr. 2018 08h30 HE
|
Scythian Biosciences Corp.
TORONTO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that the Company has received...
Scythian Biosciences Announces Closing of $28.7 Million Financing with Aphria Inc. as Lead Investor
13 févr. 2018 09h18 HE
|
Scythian Biosciences Corp.
TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that it has today closed its...
Scythian Biosciences Announces CEOs of Both Aphria and Liberty Health Sciences are Joining its Board
15 janv. 2018 08h30 HE
|
Scythian Biosciences Corp.
TORONTO, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that Mr. Vic Neufeld and Mr....
Scythian Biosciences Corp. Announces Upgrade to the OTCQB Marketplace
10 janv. 2018 09h00 HE
|
Scythian Biosciences Corp.
TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that it has been upgraded to the...
Scythian Biosciences Corp. Announces Proposed Up To 8 for 1 Stock Split
04 janv. 2018 09h00 HE
|
Scythian Biosciences Corp.
TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) announces that its Board of Directors has approved a...
Scythian Biosciences Corp. Announces Appointment of Ottis Anderson to Pro Athlete Advisory Committee
11 déc. 2017 17h07 HE
|
Scythian Biosciences Corp.
TORONTO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) is pleased to announce that it has appointed Ottis...
Scythian Biosciences Corp. Completes Sale of Go Green
30 nov. 2017 09h00 HE
|
Scythian Biosciences Corp.
TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) is pleased to announce that it has entered into a...
Scythian Retains Investor Relations Services
18 oct. 2017 17h00 HE
|
Scythian Biosciences Corp.
TORONTO, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) announces that is has entered into an agreement with...